Consortium for Intracranial Metastasis Academic Research [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.

====== Consortium for Intracranial Metastasis Academic Research ======

CIMARa ([[Consortium]] for Intracranial Metastasis Academic Research), formalized in June [[2021]], is an inclusive group of [[multidisciplinar]]y clinical [[investigator]]s, research [[scientist]]s, and advocates who share the collective [[goal]] of improving [[outcome]]s for patients with BrM. CIMARa aims to improve outcomes through the [[development]], [[coordination]], and awareness of multi-institutional [[clinical trial]]s testing novel therapeutic [[agent]]s for this unique patient [[population]], alongside the [[translation]] of preclinical research to the clinical [[setting]]
((Anders CK, Van Swearingen AED, Neman J, Joyce JA, Cittelly DM, Valiente M, Zimmer AS, Floyd SR, Dhakal A, Sengupta S, Ahluwalia MS, Nagpal S, Kumthekar PU, Emerson S, Basho R, Beal K, Moss NS, Razis ED, Yang JT, Sammons SL, Sahebjam S, Tawbi HA. Consortium for Intracranial Metastasis Academic Research (CIMARa): Global [[interdisciplinary collaboration]]s to improve outcomes of patient with [[brain metastases]]. Neurooncol Adv. 2025 Mar 4;7(1):vdaf049. doi: 10.1093/noajnl/vdaf049. PMID: 40276376; PMCID: PMC12019957.))